Laurie Glimcher MD MD
CEO and President Dana-Farber Cancer Institute, Harvard Medical School
Join to View Full Profile
1300 York AveWeill Cornell Medical CollegeNew York, NY 10065
Phone+1 212-746-6005
Dr. Glimcher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Allergy and Immunology, 1982 - 1983- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1976 - 1979
Harvard Medical SchoolClass of 1976
Certifications & Licensure
MA State Medical License 1978 - 2027
NY State Medical License 2011 - 2017
MD State Medical License 1979 - 1982
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 2 citationsIRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs.Brendan M Barton, Francheska Son, Akanksha Verma, Saswat Kumar Bal, Qianzi Tang
Nature Immunology. 2025-02-01 - 2 citationsRIOK2 transcriptionally regulates TRiC and dyskerin complexes to prevent telomere shortening.Shrestha Ghosh, Mileena T Nguyen, Ha Eun Choi, Maximilian Stahl, Annemarie Luise Kühn
Nature Communications. 2024-08-20 - Author Correction: Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1.Neal N Iwakoshi, Ann-Hwee Lee, Prasanth Vallabhajosyula, Kevin L Otipoby, Klaus Rajewsky
Nature Immunology. 2024-05-01
Press Mentions
Dana-Farber Cancer Institute Raises More Than $2 Billion in Record-Breaking Fundraising Campaign to Defy CancerSeptember 30th, 2024- Patrick McCormick Named Senior Vice President for Hospital TransformationJuly 24th, 2024
- Dana-Farber Gifted $69M for Cancer ResearchNovember 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
